Evidence map›Paper›PMID 29258992›Full record

ArticleCold Spring Harbor molecular case studies2018

Late diagnosis of a truncating

Salem Alawbathani, Amit Kawalia, Mert Karakaya, Janine Altmüller, Peter Nürnberg, Sebahattin Cirak

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. The genomic and clinical landscape of fetal akinesia.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
  3. Novel mutations inCold Spring Harbor molecular case studies · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Salem AlawbathaniCologne Center for Genomics (CCG), 50931 Cologne, Germany.
Amit KawaliaCologne Center for Genomics (CCG), 50931 Cologne, Germany.
Mert KarakayaCenter for Molecular Medicine Cologne (CMMC), 50931 Cologne, Germany.
Janine AltmüllerCologne Center for Genomics (CCG), 50931 Cologne, Germany.
Peter NürnbergCologne Center for Genomics (CCG), 50931 Cologne, Germany.
Sebahattin CirakCenter for Molecular Medicine Cologne (CMMC), 50931 Cologne, Germany.
University Hospital Cologne · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare diseases are often misdiagnosed or receive a delayed diagnosis; thus, unfortunately, affected individuals may not receive optimal medical management. Here, we report a case of two siblings with a severe phenotype of progressive pseudorheumatoid dysplasia (PPD). Their onset of symptoms began at the age of 3 yr. Both were neglected in the past, and the patients presented with a very severe phenotype and unmitigated natural history. PPD is a rare autosomal recessive skeletal dysplasia characterized by progressive joint stiffness, swelling, and pain. Because of observed muscle wasting, weakness, and the lack of laboratory testing, the case had been initially misdiagnosed by the local physicians. We aimed to provide diagnostic support by a targeted next-generation sequencing gene panel (Illumina TruSight One) for Mendelian diseases (Mendeliome), and we identified a homozygous frameshift mutation in the gene

Indexed as

Base SequenceCCN Intercellular Signaling ProteinsChild, PreschoolFamilyFemaleHumansJoint DiseasesMaleMutationPedigreePhenotypeYoung AdultCCN6 protein, humanCCN Intercellular Signaling Proteinsjoint swellingprogressive joint destruction

Identifiers

PMID29258992
PMCPMC5793772
OpenAlexW2776234774

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.